Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Crenolanib besylate

EU orphan designation number: EU/3/16/1748   
Active ingredient: Crenolanib besylate
Indication: Treatment of acute myeloid leukemia
Sponsor: Arog Pharmaceuticals Europe Ltd
C/O TMF Group, 3rd floor, Kilmore House, Park Lane, Spencer Dock, Dublin 1, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/147/16 (2016)6739 of 14/10/2016